Literature DB >> 11562252

Computational approaches towards the rational design of drug-like compound libraries.

H Matter1, K H Baringhaus, T Naumann, T Klabunde, B Pirard.   

Abstract

During the practice of combinatorial chemistry, it has been realized that molecular diversity is not the only essential feature in a synthetically feasible library. In addition, it is of utmost importance to enrich potential libraries with those molecules which could be converted to viable drug candidates. Given the enormous number of potentially synthesizable compounds, there is a need to design a subset of true "drug-like" compounds. In addition, a paradigm shift in drug discovery has resulted in the integration of pharmacokinetic and drug development activities into early stages of lead discovery. In particular, in silico filters are being developed and used to help identify and screen out compounds that are unlikely to become drugs. This paper highlights recent computational approaches towards the design of drug-like compound libraries, in particular, the prediction of drug-likeness in a more general sense as well as intestinal absorption through passive transport, the permeation of the blood-brain barrier and recent developments towards identification of potentially metabolically unstable molecules. Current computational tools for library design allow the incorporation of medicinal chemistry knowledge into library planning by a variety of methods, ranging from the use of privileged building blocks and simple counting of structural properties (e.g. number of hydrogen bonding partners) to relatively complex regression or neural network-based models to explain oral bioavailability and other pharmacokinetic properties by structural features. These tools are being incorporated more frequently into drug design according to the "rule-of-five" which refers to simple descriptors correlated to oral drug absorption. Combining experimental knowledge with effective computational filtering and prediction of various aspects of drug-likeness thus facilitates the rapid and cost-effective elimination of poor candidates prior to synthesis and helps focus attention on interesting molecules.

Entities:  

Mesh:

Year:  2001        PMID: 11562252     DOI: 10.2174/1386207013330896

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  8 in total

1.  Advances in Nuclear Magnetic Resonance for Drug Discovery.

Authors:  Robert Powers
Journal:  Expert Opin Drug Discov       Date:  2009-10-01       Impact factor: 6.098

2.  Determining the optimal size of small molecule mixtures for high throughput NMR screening.

Authors:  Kelly A Mercier; Robert Powers
Journal:  J Biomol NMR       Date:  2005-03       Impact factor: 2.835

3.  Discovery of Melanocortin Ligands via a Double Simultaneous Substitution Strategy Based on the Ac-His-dPhe-Arg-Trp-NH2 Template.

Authors:  Aleksandar Todorovic; Cody J Lensing; Jerry Ryan Holder; Joseph W Scott; Nicholas B Sorensen; Carrie Haskell-Luevano
Journal:  ACS Chem Neurosci       Date:  2018-06-11       Impact factor: 4.418

4.  Automated docking with protein flexibility in the design of femtomolar "click chemistry" inhibitors of acetylcholinesterase.

Authors:  Garrett M Morris; Luke G Green; Zoran Radić; Palmer Taylor; K Barry Sharpless; Arthur J Olson; Flavio Grynszpan
Journal:  J Chem Inf Model       Date:  2013-03-29       Impact factor: 4.956

5.  Target-independent prediction of drug synergies using only drug lipophilicity.

Authors:  Kaan Yilancioglu; Zohar B Weinstein; Cem Meydan; Azat Akhmetov; Isil Toprak; Arda Durmaz; Ivan Iossifov; Hilal Kazan; Frederick P Roth; Murat Cokol
Journal:  J Chem Inf Model       Date:  2014-08-01       Impact factor: 4.956

6.  Huanglian decoction suppresses the growth of hepatocellular carcinoma cells by reducing CCNB1 expression.

Authors:  Min Li; Hua Shang; Tao Wang; Shui-Qing Yang; Lei Li
Journal:  World J Gastroenterol       Date:  2021-03-14       Impact factor: 5.742

7.  Novel phytochemical-antibiotic conjugates as multitarget inhibitors of Pseudomononas aeruginosa GyrB/ParE and DHFR.

Authors:  Premkumar Jayaraman; Kishore R Sakharkar; ChuSing Lim; Mohammad Imran Siddiqi; Sarinder K Dhillon; Meena K Sakharkar
Journal:  Drug Des Devel Ther       Date:  2013-06-17       Impact factor: 4.162

Review 8.  Capter 11 Filtering in Drug Discovery.

Authors:  Christopher A Lipinski
Journal:  Annu Rep Comput Chem       Date:  2005-10-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.